Deguelin Action Involves c-Met and EGFR Signaling Pathways in Triple Negative Breast Cancer Cells

BACKGROUND: Treatment of breast cancer patients with antiestrogens and aromatase inhibitor(s) or Herceptin have shown significant success in steroid receptor positive or Her-2+ breast cancers respectively. However, choice of treatments for breast cancer patients with negative status for estrogen, pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehta, Rajeshwari, Katta, Harshadadevi, Alimirah, Fatouma, Patel, Rutulkumar, Murillo, Genoveva, Peng, Xinjian, Muzzio, Miguel, Mehta, Rajendra G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3677900/
https://www.ncbi.nlm.nih.gov/pubmed/23762292
http://dx.doi.org/10.1371/journal.pone.0065113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3677900/
https://www.ncbi.nlm.nih.gov/pubmed/23762292
http://dx.doi.org/10.1371/journal.pone.0065113

Ejemplares similares